Intermune (ITMN) volatility elevated into IBF drug decision

December 13, 2010 8:13 AM EST Send to a Friend
Intermune (Nasdaq: ITMN) is waiting for a decision from the EU ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login